期刊文献+

靶向HPV 16-E5的siRNA对TRAIL诱导宫颈癌Caski细胞凋亡的影响 被引量:1

Effect on apoptosis mediated by TRAIL against Caski cells of HPV16-E5-targeted siRNA
原文传递
导出
摘要 目的探讨靶向人乳头瘤病毒16早期蛋白5(HPV16-E5)的siRNA对TRAIL蛋白诱导子宫颈癌Caski细胞株凋亡的调节作用。方法 HPV16-E5特异性siRNA转染48 h后,RT-PCR检测HPV16-E5 mRNA的表达;流式细胞术及caspase-8活性检测试剂盒分别检测空白对照组、siRNA-E5单独作用组、TRAIL单独作用组、siRNA-E5+TRAIL作用组、无关序列RNA+TRAIL作用组细胞的凋亡率及caspase-8的活性水平;RT-PCR及Western blotting检测siRNA干扰后Caski细胞表面TRAIL死亡受体DR4、DR5的表达。结果 RT-PCR检测结果显示,转染48 h后,siRNA-E5组HPV16-E5 mRNA的表达较空白对照组和无关序列对照组下调(P<0.05);siRNA-E5+TRAIL作用组较TRAIL单独作用组相比细胞凋亡率明显增加(P<0.05),而无关序列RNA+TRAIL作用组较TRAIL单独作用组细胞凋亡率无明显变化(P>0.05);siRNA-E5组TRAIL受体DR4、DR5的表达较无关序列对照组、空白对照组无明显差异(P>0.05);caspase-8活性水平在siRNA-E5+TRAIL作用组明显较TRAIL单独作用组高,差异有统计学意义(P<0.05)。结论靶向HPV16-E5的siRNA可增强TRAIL诱导宫颈癌Caski细胞的凋亡作用,其机制与增强caspase-8的活化有关。 Objective To discuss the effect of Human Papilloma Virus 16 early protein 5 (HPV16-E5)-targeted siRNA on Caski cells apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL). Methods HPV16-E5-targeted siRNA was transfected into Caski cells by lipofectamine. Forty-eight hours after the transfection, the expression of E5 mRNA was detected by RT- PCR; Cell apoptosis and caspase-8 activities in the blank control group, siRNA-E5-treated group, TRAIL-treated group, siRNA-E5 + TRAIL-treated group and negative RNA + TRAIL-treated group were deter- mined by flow cytometry and caspase-8 Activity Assay Kit. The expressions of receptors DR4 and DR5 on cell surface after RNA interference were tested by Real-Time PCR and Western blotting. Results RT-PCR revealed that the ex- pression of HPV16-E5 mRNA in the siRNA-E5 group was significantly lower than that in the blank and the negative control groups ( P 〈 0.05 ) ; The cell apoptosis rate in siRNA-E5 + TRAIL group was significantly higher than that in the TRAIL group (P 〈 0.05 ). There was no significant difference in cell apoptosis rate between the negative RNA + TRAIL group and the TRAIL group( P 〉 0.05 ) ; There was no difference in the expressions of receptors DR4 and DR5 after RNA interference ( P 〉 0.05 ) ; The activity of caspase-8 in siRNA-E5 + TRAIL group was higher than that in TRAIL group, and the difference was statistical significant( P 〈 0.05 ). Conclusion HPV16-E5-Targeted siRNA could enhance the apoptosis mediated by TRAIL against Caski cancer cells in vitro, and the mechanism may be related to the increase of caspase-8 activity.
出处 《山东大学学报(医学版)》 CAS 北大核心 2013年第10期24-28,共5页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金(Y2006C44)
关键词 子宫颈肿瘤 TRAIL蛋白 SIRNA 细胞凋亡 半胱氨酸天冬氨酸蛋白酶8 Cervix neoplasms TRAIL protein siRNA Cell apoptosis Caspase-8
  • 相关文献

参考文献18

  • 1Zur Hausen H. Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer [J]. J Natl Cancer Inst, 2001, 93(4) :252-253.
  • 2Wiley S R, Schooley K, Smolask P J, et al. Identification and characterization of new member of the TNF family that induces apoptosis[J]. Immunity, 1995, 3 ( 6 ) : 673-682.
  • 3叶记林,刘永春,于有江,刘延庆.TRAIL诱导Hela细胞凋亡的线粒体信号通路[J].基础医学与临床,2011,31(10):1120-1123. 被引量:5
  • 4Cobum G A, Cullen B R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference [J]. Virol, 2002, 76 ( 18 ) : 9225-9231.
  • 5Shlomai A, Shaul Y. Inhibition of hepatitis B virus ex- pression and replication by RNA interference [J]. Hepatology, 2003, 37(4) :764-770.
  • 6Butz K, Ristriani T, Hengstermann A, et al. siRNA tar- geting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells [J]. Oncogene, 2003, 22 ( 38 ) :5938-5945.
  • 7Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA-interference [J]. Oncogene, 2002, 21 (39) :6041-6048.
  • 8Oh J M, Kim S H, Lee Y I, et al. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-de- pendent pathways in cervical cancer cells [J]. Carcinogenesis, 2009, 30( 1 ) : 141-149.
  • 9张晓,王传新,李伟,郑桂喜,张建,阚士锋,王立水.特异性siRNA抑制HPV16 E7基因表达的实验研究[J].山东大学学报(医学版),2009,47(11):64-67. 被引量:2
  • 10Chang J T, Kuo T F, Chen Y J, et al. Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers[J]. Cancer Gene Therapy, 2010, 17(12) :827-836.

二级参考文献21

  • 1Fiona C. KIMBERLEY,Gavin R. SCREATON.Following a TRAIL: Update on a ligand and its five receptors[J].Cell Research,2004,14(5):359-372. 被引量:27
  • 2Zanotti K M, Belinson J. Update on the diagnosis and treatment of human papillomavirus infection[J]. Cleve Clin J Med, 2002, 69(12) : 948-961.
  • 3McCree D H, Leichliter J S, Hogben M, et al. National survey by specialty of U.S. physicians' HPV screening practices[J]. Pre Med, 2003, 36(2) : 159-163.
  • 4Elbashir S M, Martinez J, Patkaniowska A, et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate [ J ]. EMBO J, 2001, 20 (23) : 6877-6888.
  • 5Jonson A L, Rogers L M, Ramakrishnan S, et al. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer[J]. Gynecol Oncol, 2008, 111(2) :356-364.
  • 6Folini M, Pennati M, Zaffaroni N. RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets[J]. Methods Mol Biol, 2009, 487 : 303-330.
  • 7Yoshinouchi M, Yamada T, Kizaki M, et al. In vitro and in vivo growth suppression of human papillomavirus 16 positive cervical cancer cells by E6 siRNA [ J ]. Mol Ther, 2003, 8 (5) :762-768.
  • 8Harborth J, Arborth J, Elbashir S M, et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing[J]. Antisense Nucleic Acid Drug Dev, 2003, 13(2):83-105.
  • 9Khammanivong V, Liu X S, Liu W J, et al. Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16[J]. Immanol Cell Biol, 2003, 81(1):1-7.
  • 10Wang J F, Wang C X, Wang L S, et al. Association of human papillomavims type 16 E7 and HIA class Ⅰ antigen expression in cervical premahgnant and malignant lesions [ J ]. Int J Biol Markers, 2007, 22(2) : 124-131.

共引文献7

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部